J Erickson

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

C. Boucher, S. Gulnik, J. Erickson, 1999, AIDS.

The effect of receptor density on the forward rate constant for binding of ligands to cell surface receptors.

J. Erickson, B. Goldstein, B. Baird, 1987, Biophysical journal.

Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.

A Wlodawer, A. Wlodawer, I. Weber, 1998, Biochemistry.

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.

D. Norbeck, D. Kempf, J. Erickson, 1990, Science.